<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2020-33-58-61</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-1851</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Нейропсихиатрические особенности текущей пандемии COVID‑19 (анализ зарубежных публикаций 2020 года)</article-title><trans-title-group xml:lang="en"><trans-title>Neuropsychiatric features of current COVID-19 pandemic (analysis of foreign publications in 2020)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мадонов</surname><given-names>П. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Madonov</surname><given-names>P. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. кафедрой фармакологии, клинической фармакологии и доказательной медицины</p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хидирова</surname><given-names>Л. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Khidirova</surname><given-names>L. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., доцент кафедры фармакологии, клинической фармакологии и доказательной медицины</p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Деришева</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Derisheva</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н., ассистент кафедры фармакологии, клинической фармакологии и доказательной медицины</p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Новосибирский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>14</day><month>01</month><year>2021</year></pub-date><volume>0</volume><issue>33</issue><issue-title>Неврология и психиатрия (4)</issue-title><fpage>58</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мадонов П.Г., Хидирова Л.Д., Деришева Д.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Мадонов П.Г., Хидирова Л.Д., Деришева Д.А.</copyright-holder><copyright-holder xml:lang="en">Madonov P.G., Khidirova L.D., Derisheva D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/1851">https://www.med-alphabet.com/jour/article/view/1851</self-uri><abstract><p>В статье представлен обзор научной литературы, содержащий данные об особенностях нейропсихиатрических расстройств – осложнениях со стороны нервной системы на фоне вирусной нагрузки, вызванной SARS-CoV-2 COVID-19, причинами возникновения которых могут быть чрезмерный иммунный ответ и повышение проницаемости ГЭБ. Непрямое действие вируса по типу энцефалопатии, миопатии, нейропатии критических состояний может быть обусловлено гипоксией, респираторным и метаболическим ацидозом, дисрегуляцией гомеостаза вследствие органной недостаточности, а также аутоиммунными воспалительными и демиелинизирующими процессами. Связываясь с рецепторами, АПФ2, который является сердечно-мозговым сосудистым фактором защиты различных органов, нервной системы и скелетных мышц и является мишенью для различных видов коронавирусов, в том числе SARS-CoV-2, могут вызывать повышение артериального давления основной фактор риска ОНМК. Таким образом, проспективный нейропсихиатрический мониторинг людей, подвергшихся воздействию SARS-CoV-2 на различных этапах жизненного цикла, а также их нейроиммунный статус необходимы для полного понимания долгосрочного воздействия COVID-19 и создания основы для интеграции психонейроиммунологии в эпидемиологические исследования пандемий.</p></abstract><trans-abstract xml:lang="en"><p>The article presents a review of the scientific literature containing data on the features of neuropsychiatric disorders – complications from the nervous system against the background of viral load caused by SARS-CoV-2 COVID-19. Indirect effects of the virus such as encephalopathy, myopathy, and critical neuropathy can be caused by hypoxia, respiratory and metabolic acidosis, dysregulation of homeostasis due to organ failure, and autoimmune inflammatory and demyelinating processes. Binding to the receptors of APF2, which is a cardiovascular protection factor for various organs, the nervous system and skeletal muscles is a target for various types of coronaviruses, including SARS-CoV-2 can cause an increase in blood pressure- the main risk factor for ONMC. Thus, prospective neuropsychiatric monitoring of people exposed to SARS-CoV-2 at various stages of the life cycle, as well as their neuroimmune status, is necessary to fully understand the long-term impact of COVID-19 and to provide a basis for integrating psychoneuroimmunology into epidemiological studies of pandemics.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Covid-19</kwd><kwd>SARS-CoV-2</kwd><kwd>невроз</kwd><kwd>психопатия</kwd><kwd>нейроиммунный статус</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Covid-19</kwd><kwd>SARS-CoV-2</kwd><kwd>neurosis</kwd><kwd>psychopathy</kwd><kwd>neuroimmune status</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jonathan P., Edward C., Dominic O., et al. Рsychiatric and neuropsychiatric manifestations associated with severe coronavirus infections: a systematic review and meta-analysis compared to the COVID-19 pandemic Meta-Analysis Lancet psychiatry 2020 Jul; 7 (7): 611–627. DOI: 10.1016/s2215–0366(20)30203–0. Epub 2020 May 18.</mixed-citation><mixed-citation xml:lang="en">Jonathan P., Edward C., Dominic O., et al. Рsychiatric and neuropsychiatric manifestations associated with severe coronavirus infections: a systematic review and meta-analysis compared to the COVID-19 pandemic Meta-Analysis Lancet psychiatry 2020 Jul; 7 (7): 611–627. DOI: 10.1016/s2215–0366(20)30203–0. Epub 2020 May 18.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mao, R., Liang, J., Shen J., Ghosh S., Zhu L.-R., Yang H., et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5 (5): 425–27. doi:10.1016/S2468–1253(20)30076–5</mixed-citation><mixed-citation xml:lang="en">Mao, R., Liang, J., Shen J., Ghosh S., Zhu L.-R., Yang H., et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5 (5): 425–27. doi:10.1016/S2468–1253(20)30076–5</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., et al. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B 10, 766–788. DOI: 10.1016/j.apsb.2020.02.008.</mixed-citation><mixed-citation xml:lang="en">Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., et al. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B 10, 766–788. DOI: 10.1016/j.apsb.2020.02.008.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zubair S. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 by Adeel in JAMA Neurology. Published online May 2020. DOI: 10.1001/jamaneurol.2020.2065.</mixed-citation><mixed-citation xml:lang="en">Zubair S. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 by Adeel in JAMA Neurology. Published online May 2020. DOI: 10.1001/jamaneurol.2020.2065.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19 [published online ahead of print, 2020 Apr 10]. Brain Behav Immun. 2020; S 08891591(20)30465–7.2020; 10.1212/WNL.0000000000009848.</mixed-citation><mixed-citation xml:lang="en">Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19 [published online ahead of print, 2020 Apr 10]. Brain Behav Immun. 2020; S 08891591(20)30465–7.2020; 10.1212/WNL.0000000000009848.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus. The authors declare no disease 2019 in Wuhan, China [published online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020; 77 (6): 1–9.</mixed-citation><mixed-citation xml:lang="en">Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus. The authors declare no disease 2019 in Wuhan, China [published online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020; 77 (6): 1–9.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Natali M., Zubair S. et al. Distribution of the ‘entrance gate’ in the brain for the new SARS-CoV-2 coronavirus – angiotensin-converting enzyme 2 (ACE 2) receptors. Credit: Adeel / JAMA Neurology 2020.</mixed-citation><mixed-citation xml:lang="en">Natali M., Zubair S. et al. Distribution of the ‘entrance gate’ in the brain for the new SARS-CoV-2 coronavirus – angiotensin-converting enzyme 2 (ACE 2) receptors. Credit: Adeel / JAMA Neurology 2020.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.</mixed-citation><mixed-citation xml:lang="en">Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; 10.1007/s00059–020–04909-z. DOI: 10.1007/s00059–020–04909-z.</mixed-citation><mixed-citation xml:lang="en">Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; 10.1007/s00059–020–04909-z. DOI: 10.1007/s00059–020–04909-z.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., Chang, C., 2020 The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity 102434. DOI: 10.1016/j.jaut.2020.102434.</mixed-citation><mixed-citation xml:lang="en">Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., Chang, C., 2020 The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity 102434. DOI: 10.1016/j.jaut.2020.102434.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A. et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013. Vol. 13, N 9. P. 752–761. DOI: 10.1016/S1473–3099(13)70204–4.</mixed-citation><mixed-citation xml:lang="en">Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A. et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013. Vol. 13, N 9. P. 752–761. DOI: 10.1016/S1473–3099(13)70204–4.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zeppegno, P., Gramaglia, C., Guerriero, C., Madeddu, F., &amp; Calati, R. (2020, May 17). Psychological/psychiatric impact of the novel coronavirus outbreak: lessons learnt from China and call for timely crisis interventions in Italy. doi:10.31234/osf.io/z26yk</mixed-citation><mixed-citation xml:lang="en">Zeppegno, P., Gramaglia, C., Guerriero, C., Madeddu, F., &amp; Calati, R. (2020, May 17). Psychological/psychiatric impact of the novel coronavirus outbreak: lessons learnt from China and call for timely crisis interventions in Italy. doi:10.31234/osf.io/z26yk</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C, Wang Y, Li X, Ren L, et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet China. doi:10.1016/S0140–6736(20)30183–5.</mixed-citation><mixed-citation xml:lang="en">Huang C, Wang Y, Li X, Ren L, et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet China. doi:10.1016/S0140–6736(20)30183–5.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yakhontov D. A. Introduction to evidence-based medicine [Electronic resource]: textbook / D. A. Yakhontov; ed.– Novosibirsk: Sibmedia the ngma, 2006.– 105 http://library.ngmu.ru/search/view?mfn=23123&amp;irbisBase=MAIN.</mixed-citation><mixed-citation xml:lang="en">Yakhontov D. A. Introduction to evidence-based medicine [Electronic resource]: textbook / D. A. Yakhontov; ed.– Novosibirsk: Sibmedia the ngma, 2006.– 105 http://library.ngmu.ru/search/view?mfn=23123&amp;irbisBase=MAIN.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Novohatsky A. V. Principles of evidence-based medicine in clinical psychology: a modern approach to making objective clinical decisions. Bulletin Of SUSU Psychology; 2010; 17 (6): 85–89 https://cyberleninka.ru/article/n/printsipy-dokazatelnoy-meditsiny-v-klinicheskoy-psihologii-sovremennyy-podhod-k-prinyatiyu-obektivnyh-klinicheskih-resheniy.</mixed-citation><mixed-citation xml:lang="en">Novohatsky A. V. Principles of evidence-based medicine in clinical psychology: a modern approach to making objective clinical decisions. Bulletin Of SUSU Psychology; 2010; 17 (6): 85–89 https://cyberleninka.ru/article/n/printsipy-dokazatelnoy-meditsiny-v-klinicheskoy-psihologii-sovremennyy-podhod-k-prinyatiyu-obektivnyh-klinicheskih-resheniy.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Asadi-Pooya, AA, Simani, L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020; 413: 116832. DOI: 10.1016/j.jns.2020.116832.</mixed-citation><mixed-citation xml:lang="en">Asadi-Pooya, AA, Simani, L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020; 413: 116832. DOI: 10.1016/j.jns.2020.116832.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S, Manson J. J. COVID-19: consider cytokine storm syndromes and immunosupression. Lancet. 2020; 395 (10229): 1033–34. doi:10.1016/S0140–6736(20)30628–0.</mixed-citation><mixed-citation xml:lang="en">Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S, Manson J. J. COVID-19: consider cytokine storm syndromes and immunosupression. Lancet. 2020; 395 (10229): 1033–34. doi:10.1016/S0140–6736(20)30628–0.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Du R. H., Li B., Xu D., Wang J., Li Z., Lin J. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9 (1): 386–9. doi:10.1080/22221751.2020.1729071</mixed-citation><mixed-citation xml:lang="en">Zhang W., Du R. H., Li B., Xu D., Wang J., Li Z., Lin J. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9 (1): 386–9. doi:10.1080/22221751.2020.1729071</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mikkelsen, M. D., Naur, P. and Halkier, B. A. (2012). Arabidopsis mutants in theC-S lyase of glucosinolate biosynthesis establish a critical role for indole-3-acetaldoxime in auxin homeostasis. Plant J. 37, 770–777.</mixed-citation><mixed-citation xml:lang="en">Mikkelsen, M. D., Naur, P. and Halkier, B. A. (2012). Arabidopsis mutants in theC-S lyase of glucosinolate biosynthesis establish a critical role for indole-3-acetaldoxime in auxin homeostasis. Plant J. 37, 770–777.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Luo et al. J Zhejiang Univ-Sci A (Appl Phys &amp; Eng) 2014, 15 (8): 593–605. DOI: 10.1631/jzus.A1400111.</mixed-citation><mixed-citation xml:lang="en">Luo et al. J Zhejiang Univ-Sci A (Appl Phys &amp; Eng) 2014, 15 (8): 593–605. DOI: 10.1631/jzus.A1400111.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020). Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 63, 706–711. https://doi.org/10.1007/s11427–020–1661–4</mixed-citation><mixed-citation xml:lang="en">Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020). Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 63, 706–711. https://doi.org/10.1007/s11427–020–1661–4</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Erin T. Kaseda &amp; Andrew J. Levine (2020) Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 34: 7–8, 1498–1514. DOI: 10.1080/13854046.2020.1811894.</mixed-citation><mixed-citation xml:lang="en">Erin T. Kaseda &amp; Andrew J. Levine (2020) Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 34: 7–8, 1498–1514. DOI: 10.1080/13854046.2020.1811894.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Statsenko O. A. clinical case of acute transient psychosis against the background of the COVID-19 pandemic. Omsk Psychiatric Journal. 2020; 2 (24): 23–29 (in Russ) DOI: 10.24411/2412–8805–2020–10204.</mixed-citation><mixed-citation xml:lang="en">Statsenko O. A. clinical case of acute transient psychosis against the background of the COVID-19 pandemic. Omsk Psychiatric Journal. 2020; 2 (24): 23–29 (in Russ) DOI: 10.24411/2412–8805–2020–10204.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Quan Y, Huang A, Ye M, Xu M, Zhuang B, Zhang P, Yu B, Min Z. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015; 17: 2015.</mixed-citation><mixed-citation xml:lang="en">Quan Y, Huang A, Ye M, Xu M, Zhuang B, Zhang P, Yu B, Min Z. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015; 17: 2015.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lechowicz, K.; Drożdżal, S.; Machaj, F.; Rosik, J.; Szostak, B.; Zegan-Barańska, M.; Biernawska, J.; Dabrowski, W.; Rotter, I.; Kotfis, K. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J. Clin. Med. 2020, 9, 1917.</mixed-citation><mixed-citation xml:lang="en">Lechowicz, K.; Drożdżal, S.; Machaj, F.; Rosik, J.; Szostak, B.; Zegan-Barańska, M.; Biernawska, J.; Dabrowski, W.; Rotter, I.; Kotfis, K. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J. Clin. Med. 2020, 9, 1917.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Guan W. J., Ni Z. Y., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 Feb 28. DOI: 10.1056/NEJMoa2002032.</mixed-citation><mixed-citation xml:lang="en">Guan W. J., Ni Z. Y., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 Feb 28. DOI: 10.1056/NEJMoa2002032.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Cai L., Cheng Z. S. et al. Быстрого советы рекомендации по диагностике и лечению синдрома Роман 2019 (2019-Н ков), инфицированных пневмонией (стандартная версия). мил. Мед. Рез. 2020. Том 7, N 1. С. 4.</mixed-citation><mixed-citation xml:lang="en">Cai L., Cheng Z. S. et al. Быстрого советы рекомендации по диагностике и лечению синдрома Роман 2019 (2019-Н ков), инфицированных пневмонией (стандартная версия). мил. Мед. Рез. 2020. Том 7, N 1. С. 4.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Meng T., Cao H., Zhang H., et al. The transmembrane serine protease inhibitors are potential antiviral drugs for 2019-nCoV targeting the insertion sequence-induced viral infectivity enhancement/ Posted February 11, 2020. doi:10.1101/2020.02.08.926006</mixed-citation><mixed-citation xml:lang="en">Meng T., Cao H., Zhang H., et al. The transmembrane serine protease inhibitors are potential antiviral drugs for 2019-nCoV targeting the insertion sequence-induced viral infectivity enhancement/ Posted February 11, 2020. doi:10.1101/2020.02.08.926006</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Winkler P., Formanek T., Mlada K et al. Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys. Published online by Cambridge University Press: 29 September 2020, pp. 1–17.</mixed-citation><mixed-citation xml:lang="en">Winkler P., Formanek T., Mlada K et al. Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys. Published online by Cambridge University Press: 29 September 2020, pp. 1–17.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmerman M, Clark H, McGonigal P, Harris L, Guzman Holst C, Martin J. Relationship between the DSM-5 anxious distress specifier and the hamilton depression rating scale anxiety/ somatization factor. J Nerv Ment Dis. 2018; 206: 152–154.</mixed-citation><mixed-citation xml:lang="en">Zimmerman M, Clark H, McGonigal P, Harris L, Guzman Holst C, Martin J. Relationship between the DSM-5 anxious distress specifier and the hamilton depression rating scale anxiety/ somatization factor. J Nerv Ment Dis. 2018; 206: 152–154.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Weekly. 2020; 2 (8): 113–22.</mixed-citation><mixed-citation xml:lang="en">The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Weekly. 2020; 2 (8): 113–22.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Helms, J., Kremer, S., Merdji, H., et al. Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine, 2020; 382 (23), 2268–2270. doi:10.1056/NEJMc2008597</mixed-citation><mixed-citation xml:lang="en">Helms, J., Kremer, S., Merdji, H., et al. Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine, 2020; 382 (23), 2268–2270. doi:10.1056/NEJMc2008597</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
